Eukles Asset Management Johnson & Johnson Transaction History

Eukles Asset Management

$227 Million
Q2 2024

A detailed history of Eukles Asset Management transactions in Johnson & Johnson stock. As of the latest transaction made, Eukles Asset Management holds 11,944 shares of JNJ stock, worth $1.97 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

11,944

Previous 11,852 0.78%

Holding current value

$1.97 Million

Previous $1.87 Million 6.88%

% of portfolio

0.77%

Previous 0.82%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$144.38 - $157.78 $13,282 - $14,515	92 Added 0.78%	11,944 $1.75 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $86,767 - $90,971	559 Added 4.95%	11,852 $1.87 Million
Q4 2023 Jan 31, 2024	BUY	$145.6 - $158.88 $4,222 - $4,607	29 Added 0.26%	11,293 $1.77 Million
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $18,378 - $20,588	118 Added 1.06%	11,264 $1.75 Million
Q2 2023 Aug 01, 2023	BUY	$154.35 - $166.11 $20,528 - $22,092	133 Added 1.21%	11,146 $1.84 Million
Q1 2023 Apr 28, 2023	BUY	$151.05 - $180.26 $5,286 - $6,309	35 Added 0.32%	11,013 $1.71 Million
Q4 2022 Jan 27, 2023	BUY	$160.2 - $179.79 $59,594 - $66,881	372 Added 3.51%	10,978 $1.94 Million
Q3 2022 Oct 28, 2022	BUY	$161.33 - $179.52 $120,029 - $133,562	744 Added 7.54%	10,606 $1.73 Million
Q2 2022 Jul 28, 2022	BUY	$168.19 - $186.01 $8,914 - $9,858	53 Added 0.54%	9,862 $1.75 Million
Q1 2022 Apr 27, 2022	SELL	$158.14 - $179.59 $121,925 - $138,463	-771 Reduced 7.29%	9,809 $1.74 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $47,402 - $52,595	304 Added 2.96%	10,580 $1.81 Million
Q3 2021 Oct 28, 2021	SELL	$161.5 - $179.47 $52,487 - $58,327	-325 Reduced 3.07%	10,276 $1.66 Million
Q2 2021 Jul 27, 2021	BUY	$159.48 - $171.07 $253,094 - $271,488	1,587 Added 17.61%	10,601 $1.75 Million
Q1 2021 Apr 27, 2021	BUY	$153.07 - $170.48 $26,021 - $28,981	170 Added 1.92%	9,014 $1.48 Million
Q4 2020 Jan 26, 2021	BUY	$137.11 - $157.38 $26,050 - $29,902	190 Added 2.2%	8,844 $1.39 Million
Q3 2020 Oct 29, 2020	BUY	$140.38 - $153.83 $15,722 - $17,228	112 Added 1.31%	8,654 $1.29 Million
Q2 2020 Jul 29, 2020	BUY	$128.81 - $155.51 $143,236 - $172,927	1,112 Added 14.97%	8,542 $1.2 Million
Q1 2020 Apr 22, 2020	SELL	$111.14 - $153.99 $141,703 - $196,337	-1,275 Reduced 14.65%	7,430 $974,000
Q4 2019 Jan 24, 2020	SELL	$127.5 - $146.44 $14,280 - $16,401	-112 Reduced 1.27%	8,705 $1.27 Million
Q3 2019 Oct 29, 2019	SELL	$126.95 - $142.14 $3,046 - $3,411	-24 Reduced 0.27%	8,817 $1.14 Million
Q2 2019 Aug 01, 2019	SELL	$131.15 - $144.24 $8,000 - $8,798	-61 Reduced 0.69%	8,841 $1.23 Million
Q1 2019 Apr 23, 2019	BUY	$125.72 - $139.79 $3,394 - $3,774	27 Added 0.3%	8,902 $1.24 Million
Q4 2018 Jan 22, 2019	BUY	$122.84 - $147.84 $1.09 Million - $1.31 Million	8,875 New	8,875 $1.15 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.

Account

Eukles Asset Management Johnson & Johnson Transaction History